semaglutide and optic neuritis Wegovy may raise risk of ischemic neuropathy ποΈ The obesity drug semaglutide, marketed as Wegovy, was associated with a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic Semaglutide linked to increased risk
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 25 - Aug 30

























